Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irosustat + AI in ER+ Advanced Breast Cancer
NCT01785992Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Oct 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irosustat in breast cancer, sponsored by Imperial College London. Started Oct 2012; status: completed.
02
Drugs
irosustat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01785992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01785992.